26 June 2020
Latham & Watkins Advises Enko Chem in its US$45 Million Series B Financing
Venture Capital & Growth Announced
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Kristen Grannis Lead | Latham & Watkins LLP | Partner | corporate | Boston |
| Spencer Ricks | Latham & Watkins LLP | Associate | corporate | Boston |
| Peter Prial | Latham & Watkins LLP | Associate | corporate | Boston |
| Tyler Mills | Latham & Watkins LLP | Associate | corporate | Boston |
Stated terms
- Stated value
- USD 45m (US$45 million)
- What the figure measures
- Issue size
- Client
- Enko Chem, Inc.Issuer
- Counterparties
- Bill & Melinda Gates Foundation (Investor)
Anterra Capital (Investor)
Rabobank (Investor)
Finistere Ventures (Investor)
Novalis LifeSciences (Investor)
Germin8 Ventures (Investor)
TO Ventures Food (Investor)